Programmable Logic Controllers
Control System targets bio-processing industry.
Press Release Summary:
Using standard PLCs and distributed control systems, i-ControlXL offers scientists and engineering communities intuitive navigation, color touch screen interface, and options for bioreactor controls, pumps, and sensors. Same system can be used to control autoclavable vessels, single-use bioreactors, or SIP/CIP systems. Fieldbus-based unit provides engineers with open system architecture and choice of controllers including Siemens, Allen Bradley, or Delta V.
Original Press Release:
Applikon Biotechnology Announces Important Breakthrough for the BioProcessing Market
SCHIEDAM, The Netherlands, June 7// --Applikon Biotechnology B.V., a leading manufacturer and supplier of high quality bioreactor systems, announces the launch of i-ControlXL, a significant breakthrough for the BioProcessing market. Applikon's products are used by the pharmaceutical, food, and chemical and process industries as well as research centres.
i-ControlXL is an easy-to-use platform and follows Applikon Biotechnology's 30 years' experience in bio-process control. Specifically designed for the bio-process industry, it offers industrial power, reliability and expandability using standard controllers (PLC) and distributed control systems (DCS).
As a result of i-ControlXL the scientist and engineering communities will enjoy a number of benefits including: intuitive navigation; a colour touch screen interface; options for bioreactor controls, pumps and sensors; the ability to use the same system to control autoclavable vessels, single-use bioreactors or SIP/CIP systems and impressively, the power to meet today's needs but with sufficient expandability to meet future needs.
Benefits specific to engineers include: a choice of controllers including Siemens, Allen Bradley or Delta V; fieldbus technology; the power and reliably of an industrial controller; a design adhering to the S88 guidelines and open system architecture.
Hans van den Berg, [manager M&B], at Applikon Biotechnology commented, "Bioprocess related issues such as high-throughput screening, scaling up, scaling down and PAT are no longer a trend, but a must in this arena. A Manufacturing Execution Systems (MES) involves managing engineering changes and tracing material for regulatory compliance, conforming to increasingly stringent quality standards, delivering on schedule despite shrinking lead times, and reducing costs. It is becoming increasingly important. Our i-ControlXL platform addresses these issues."
Applikon Biotechnology B.V. is a Dutch company based in Schiedam, the Netherlands, which develops, manufactures and supplies bioreactor systems for both research, process development and production use.
The company Applikon B.V. started in 1973 and since its launch, Applikon has grown from a small company supplying laboratory instrumentation to a dynamic worldwide enterprise capable of supplying a broad and diverse line of bioreactor systems, from 1ml - 1.000.000ml. Applikon Biotechnology B.V. is a subsidiary of Applikon B.V.
Over the years Applikon Biotechnology has developed close collaborations with a variety of academic institutes and NGO's providing access to relevant know-how in bioprocess engineering (UBC, Vancouver; Delft University; TNO; RIVM/NVI; University Giessen; and others).
For further information, please contact: Applikon Biotechnology B.V., De Brauwweg 13, 3125 AE Schiedam, the Netherlands, Erik Kakes, T: +31-(0)10-298-3566, biotech@applikon.com
